Samsung Biologics Co.,Ltd.

Headquarters: Incheon, South Korea

Employees: 3,247

CEO: Mr. John Chongbo Rim

show_chart KRX: 207940 -0.12%

Market Cap

₩56.227 Trillion

KRW as of Jan. 1, 2023

US$44.26 Billion

history Market Cap History

Samsung Biologics Co.,Ltd. market capitalization over time

Evolution of Samsung Biologics Co.,Ltd. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Samsung Biologics Co.,Ltd.

Detailed Description

Samsung Biologics Co., Ltd. engages in the contract manufacturing organization business for biopharmaceuticals products. It is involved in the provision of contract development organization services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company has a strategic partnership agreement with Kineta, Inc. Samsung Biologics Co., Ltd. was founded in 2011 and is headquartered in Incheon, South Korea.

Stocks & Indices

Samsung Biologics Co.,Ltd. has the following listings and related stock indices.

Stock: KRX: 207940



300, Songdo Bio-daero


Incheon, 21987

South Korea

Phone: 82 3 2455 3114